Fulminant hyperammonaemia induced by thiopental coma in rats.

Toxicology

Military Toxicology and Medical Protection, Military Medical Academy, ul. Lebedeva 6, 194044 St. Petersburg, Russia.

Published: July 2006

Fulminant hyperammonaemia as a threshold effect of coma-inducing dose of sodium thiopental has been revealed in rats. Blood ammonia content increased progressively after the introduction of 1.0 LD(50) (but not 0.8 LD(50)) of sodium thiopental three times in 3h and five times in 18h. The urinary ammonia excretion was not impaired while the volatilization of ammoniac from the body of ST-treated rats was higher, giving evidence of the augmentation of ammonia production. Blood urea increased by one third despite of insignificant alterations of haematocrit and blood creatinine. Ammonia hyperproduction in the digestive tract could result from gastrointestinal stasis, which has been verified by roentgenography and confirmed by correlation of hyperammonaemia with the stool retardation. In thiopental coma rats the slope of a dose-dependent increase of the blood ammonia and the blood urea after the intraperitoneal injection of ammonium acetate did not exceed that in intact animals. So the ammonia hyperproduction in the digestive tract could be the main contributing cause of fulminant hyperammonaemia in rats with thiopental coma and thus be involved into pathogenesis of the coma.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tox.2006.04.002DOI Listing

Publication Analysis

Top Keywords

fulminant hyperammonaemia
12
thiopental coma
12
coma rats
8
sodium thiopental
8
blood ammonia
8
blood urea
8
ammonia hyperproduction
8
hyperproduction digestive
8
digestive tract
8
ammonia
6

Similar Publications

L-carnitine for valproic acid-induced toxicity.

Br J Clin Pharmacol

September 2024

National Poisons Information Service (Newcastle unit), Newcastle-upon-Tyne Hospitals NHS Foundation Trust, UK.

Aims: Review the effectiveness and dosing of L-carnitine for valproic-acid induced toxicity.

Methods: A literature review of the pharmacokinetics and clinical use of L-carnitine was performed.

Results: Valproic acid is a fatty acid used for numerous therapeutic indications ranging from epilepsy to bipolar disorder.

View Article and Find Full Text PDF

Liver disease in pregnancy can be classified into pregnancy-related, liver disease coincident with pregnancy or preexisting liver disease. Acute fatty liver of pregnancy (AFLP) is a rare liver disorder that is caused by defects in mitochondrial beta (β) oxidation of fatty acids. In view of its fulminant presentation and rapid progression to multiple organ failure (MOF), AFLP carries high maternal and fetal mortality.

View Article and Find Full Text PDF

3-Hydroxy-3-Methylglutaryl-CoA Lyase (HMGCL) deficiency can be a very severe disorder that typically presents with acute metabolic decompensation with features of hypoketotic hypoglycemia, hyperammonemia, and metabolic acidosis. A retrospective chart and literature review of Australian patients over their lifespan, incorporating acute and long-term dietary management, was performed. Data from 10 patients contributed to this study.

View Article and Find Full Text PDF

We present the case of a 6-year-old Taiwanese boy with a fulminant course of COVID-19 manifesting as high fever, acute consciousness changes, and status epilepticus. Brain MRI showed restricted diffusion in the bilateral hemisphere. Electroencephalogram showed diffuse slow waves with few spikes.

View Article and Find Full Text PDF
Article Synopsis
  • Inborn errors of ketogenesis are rare, serious metabolic disorders that typically cause acute health crises in infants and children due to lipolytic stress, specifically HMGCS and HMGCL deficiencies.* -
  • The study analyzed four patients, their clinical and biochemical data, and utilized advanced genetic testing techniques like whole-exome sequencing to diagnose and understand these conditions, noting that three cases were life-threatening.* -
  • Dietary interventions were implemented, including moderated fat intake and low leucine diets, resulting in no major health issues for the patients in the long-term follow-up, with all living individuals doing well without neurological damage.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!